Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, and Rx. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Rx segment includes oral, respiratory and other generic and specialty products supplied to the North American retail market, leveraging state-of-the-art manufacturing facility in Columbus, Ohio. The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.